Renowned scholars advise Merck on bioethics issues
Renowned scholars advise Merck on bioethics issues
© Getty Images  
The many ethics of daily life

This, in turn, directs our gaze to the fact that practical ethics can be based on a great variety of basic assumptions. From this perspective, different ethical systems are possible. For example, rule-based ethics is based on obedience to rules and laws, whereas goods-based ethics asks how proper behavior increases both material and immaterial goods, such as health.

Virtue-based ethics focuses on values such as courage and justice; in turn, utilitarian ethics uses the criterion of utility for the individual and for society as a whole. Responsibility-based ethics initially added the perspective of theology (Dietrich Bonnhoeffer) and, later on, of environmentalism (Hans Jonas).

But a philosophical discussion does not automatically generate a specific answer to the question "What can I do?", which is also asked by companies like Merck whose activities in the fields of research, development, and production have far-reaching effects on society and on our ideas about the people of the future.

In any case, Kant's answer to the question "What can I do?" was his categorical imperative, a principle that is still a benchmark in the field of ethics: "Act only according to that maxim which you can, at the same time, will to become a universal law." A positive aspect of this principle is that it does not release any individual from his or her responsibility for humanity as a whole.
The experts on the panel advise the company and open up new perspectives
The experts on the panel advise the company and open up new perspectives
© Merck  
zoom in

The Merck Bioethics Advisory Panel

Since the beginning of 2011, renowned scholars have been advising Merck on bioethics issues. "At the very first meeting of the Merck Bioethics Advisory Panel, these high-ranking experts offered us completely new perspectives on a number of issues," says Florian Bieber, Chief Medical Officer of Merck and the Chairman of the ethics council.

The panel has only an advisory function and makes no decisions. "The experts on the panel are expected to inform and sensitize us early on concerning bioethics issues that will be coming up in the future," Bieber adds. Innovative medications produced via biotechnology could relieve suffering, but in order to do so they would have to intervene in basic biological processes. Some aspects of this development are giving rise to controversy in a general public discussion.
The members of the panel represent a variety of disciplines and perspectives:

Prof. Jochen Taupitz, University of Mannheim
Professor for Civil Law, Civil Procedure Law, Private International Law, and Comparative Law

Prof. Nikolaus Knoepffler, Friedrich Schiller University of Jena
Director of the Ethics Center, Chair of Applied Ethics

Prof. Christoph Rehmann-Sutter, University of Lübeck
Professor of Theory and Ethics in the Biosciences

Prof. Jeremy Sugarman, Johns Hopkins University, Baltimore (Maryland/USA)
Harvey M. Meyerhoff Professor of Bioethics and Medicine, Professor of Medicine, Professor of Health Policy and Management

Prof. Dena S. Davis, Lehigh University, Bethlehem (Pennsylvania, USA)
Holder of the Presidential Chair in Health /Humanties and social sciences

Prof. Jeanne Loring, Scripps Research Institute, La Jolla (California, USA)
Founding Director of the Center for Regenerative Medicine

 

"Act only according to that maxim which you can, at the same time, will to become a universal law." The principles of Immanuel Kant have influenced ethics down to the present day
"Act only according to that maxim which you can, at the same time, will to become a universal law." The principles of Immanuel Kant have influenced ethics down to the present day
© Getty Images